Tenax Therapeutics (TENX) Research & Development: 2010-2016
Historic Research & Development for Tenax Therapeutics (TENX) over the last 3 years, with Dec 2016 value amounting to $6.7 million.
- Tenax Therapeutics' Research & Development was N/A to $6.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was $16.3 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2024, which is 293.59% up from last year.
- Latest data reveals that Tenax Therapeutics reported Research & Development of $6.7 million as of Q4 2016, which was up 105.73% from $3.2 million recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' Research & Development registered a high of $24.5 million during Q2 2013, and its lowest value of $369,447 during Q1 2013.
- Its 2-year average for Research & Development is $4.1 million, with a median of $3.6 million in 2016.
- Data for Tenax Therapeutics' Research & Development shows a peak YoY increase of 3,296.89% (in 2013) and a maximum YoY decrease of 38.42% (in 2013) over the last 5 years.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Research & Development stood at $604,574 in 2012, then spiked by 3,296.89% to $24.5 million in 2013, then reached $2.4 million in 2015, then reached $6.7 million in 2016.
- Its Research & Development stands at $6.7 million for Q4 2016, versus $3.2 million for Q3 2016 and $3.9 million for Q2 2016.